Arboreal Bioinnovations Private Limited (ABPL) is India’s first specialty food and nutraceutical ingredients technology company. Arboreal Bioinnovations Private Limited has raised ₹230 crore in a Series A funding round. This investment was co-led by EAAA Alternatives and Omnivore. Existing investor Rainmatter, by Zerodha, was also a part of the investment round. This deal is observed by industry experts as marking one of the largest Series A fundraisings in India’s specialty food ingredients sector.

Business expansion and technical integration

The funds raised will be directed towards three major operational areas. Arboreal Bioinnovations intends to use the ₹230 crore to scale its manufacturing, fortify research and development, and commercialise and roll out its next-generation functional ingredients.

Arboreal Bioinnovations has designed a uniquely formulated approach called the contextual innovation model. This methodology is specifically created for developing ingredient solutions based on the unique nutritional, functional, sensory, and commercial needs of Indian consumers and brands. Through the strategy, the company has enabled hundreds of emerging and challenger businesses to launch category-defining products and rapidly expand within the wider food, beverage, and nutraceutical categories.

The key component of the business is an integrated ingredient technology platform. This platform integrates ingredient engineering, process R&D, formulation science, and precision manufacturing. These integrated systems have enabled Arboreal Bioinnovations to develop and commercialize proprietary ingredients in various categories such as next-generation proteins, cocoa-based ingredients, natural zero-calorie sweeteners and functional fibres, with several other systems still under active development.

In terms of growth and financial momentum, the company has more than doubled since the prior year. During the last 18 months, Arboreal Bioinnovations has contributed to over 300 product launches for over 1,100 consumer brands and nutraceutical manufacturers.

Co-founder and Investors’ perspectives

The co-founder & CEO of Arboreal Bioinnovations, Swati Pandey, said, “This fundraise is a strong validation of the direction we are taking as a company. It gives us the fuel to accelerate our mission of building clean, science-led solutions that address some of the world’s most pressing nutritional and food challenges, with innovation originating in India and reaching consumers globally.”

The co-founder and COO of Arboreal Bioinnovations, Manish Chauhan, said, “This fundraise marks an important milestone in Arboreal’s journey from building IP-led ingredient technologies to enabling big shifts across categories through ingredient-first innovation. The confidence shown by EAAA, Omnivore and Rainmatter validates both the strength of our platform and the opportunity ahead of us. It gives us the ability to invest more deeply in science, manufacturing, talent and long-term innovation, while building a platform capable of creating differentiated ingredients for some of the world’s most important food and nutraceutical brands.”

The Managing Director, Private Equity of EAAA Alternatives, Ashish Agarwal, said, ” The investment in Arboreal reflects the core philosophy of our Fund’s strategy – backing businesses with the potential to emerge as category leaders. As the first investment from our Discovery Fund II, we are particularly excited at the long-term growth prospects of Arboreal’s next-generation yeast protein products.”

The Managing Partner of Omnivore, Jinesh Shah, said, “The shift toward clean-label and functional foods requires engineered ingredients that deliver clear health benefits without sacrificing taste or margins. Arboreal fills a critical market gap with locally developed formulations. From sweetener alternatives to novel yeast proteins and collagens, Arboreal’s R&D stack positions them to power the next wave of health and wellness brands.”

The Head of Investments at Rainmatter, Dinesh Pai, said, “We all lament that India does not allocate capital for enough R&D. Aside from all the things everyone else shared in their reasoning for the investment, we truly wanted to back Swati and Manish in building a world-class R&D team working on food ingredients from India. We believe that they are the right team, with exceptional grit to chase down this problem. Rainmatter exists to back these audacious bets, and this is one of them.”

Quotation Source: FnBnews.com 

Conclusion

The successful Series A funding round worth ₹230 crore that was co-led by EAAA Alternatives and Omnivore. Rainmatter is a significant milestone in the financial journey of Arboreal Bioinnovations and the Indian specialty ingredients sector.

The capital infusion will be used for precision manufacturing as well as nurturing research into novel ingredients and scaling up its integrated ingredient platform, helping Arboreal Bioinnovations shape the next generation of functional, clean-label product innovations for Indian households and global markets.